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METHODS
PAFR expression: Stored mouse lung tissue
Mice inhaled StS-WF composed of (weight percentage) iron (57%),
chromium (20%), manganese (13%), nickel (8%), and copper (0.2%) with
trace amounts of silicon, aluminum, and vanadium. The particle diameters
ranged from ultrafine (0.01-0.1 mm) to coarse (1.0-10 mm), with the majority
of particles in the fine size range (0.1-1.0mm). The mass median aerodynamic
diameter was 0.255 mm, with a geometric SD of 1.35. RNA from mice
exposed to aerosolized StS-WF was isolated from whole-lung homogenates
by using TRIzol (Invitrogen) and then cleaned according to themanufacturer’s
instructions with an RNeasy Mini Kit (Qiagen). A 2 mL aliquot of each RNA
sample was quantified by using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, Del). Briefly, RT-qPCR reactions
were carried out by using StepOne (Applied Biosystems, Foster City, Calif)
with predesigned Assays-on-Demand TaqMan probes and primers (Applied
Biosystems). By using 96-well plates, 1 mg of total RNA was reverse
transcribed with random hexamers (Applied Biosystems) and Superscript III
(Invitrogen). Hypoxanthine-guanine phosphoribosyltransferase was used as
the reference gene. Relative gene expression was calculated by using the
comparative cycle threshold (DDCT) method. All procedures and protocols
were approved by the Animal Care and Use Committee of the National Insti-
tute for Occupational Safety and Health.
PAFR expression: Stored human lung tissue
PAFR antigen retrieval in human lung biopsy tissue was carried out on 3-
mm paraffin wax–embedded sections dried down overnight at 608C. Slides
were placed in an EDTA buffer of pH 8.1 and microwaved at full power for
35 minutes. Slides were then transferred to a DAKO autostainer (DAKO,
Glostrup, Denmark), where they were treated with a 3% peroxidase block
followed by using the R.T.U Vectastain Kit (PK-7200; Vector Laboratories,
Burlingame, Calif), according to the manufacturer’s recommendations. The
working dilution of the human anti-PAFR mAb CAY160600 (Cayman Chem-
ical) was used at 1:100, and the incubation time was 40 minutes. The signal
was visualized by using DAKODAB1 Chromogen Solution (K3468) applied
for 5 minutes. AGills hematoxylin nuclei counterstain was used for 2minutes.
A negative control using tonsil tissue without the anti-PAFR antibody showed
no nonspecific diaminobenzidene signal.
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FIG E1. LDH release fromA549 cells exposed to 2 hours ofMS-WF (A) and BEAS-2B cells exposed to 2 hours
ofMS-WF (B). Data are from a single experiment, with 3 technical replicates. The positive control is assessed
after total cell lysis by using distilled water. MS-WF at concentrations of 400 mg/mL or less do not cause cyto-
toxicity in this assay.
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FIG E2. Effect of exposure of airway cells to 10 mg/mL (5 mg/cm2) MS-WF
in vitro for 24 hours on the adhesion of S pneumoniae to A549 cells (A)
and BEAS-2B cells (B). Increased CFU values determined by using quantita-
tive culture reflect increased pneumococcal adherence. Data are from 3
separate experiments, described as means (SEMs), and compared by using
the t test. **P < .01 versus medium control.
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FIG E3. Effect of exposure of mice to 600 mg of intranasal MS-WF
administered as 100-mg doses once a day for 6 days on S pneumoniae
CFU values in BALF (A) and lung tissue (B). Mice were infected 24 hours af-
ter instillation of the last dose of MS-WF, and CFU values were assessed by
means of qualitative culture. Data are from 6 animals per group and
compared by using the Mann-Whitney U test. Bars represent medians.
**P < .01.
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FIG E4. Effect of aerosolized StS-WF on mouse lung PAFR mRNA expres-
sion. PAFR mRNA expression was assessed by using real-time quantitative
PCR with hypoxanthine-guanine phosphoribosyltransferase as the refer-
ence gene. Relative gene expression was calculated by using the DD cycle
threshold method. A, Four hours after a 10-day course of aerosolized StS-
WF (40 mg/m3) for 3 hours. B, Twenty-eight days after a 10-day course of
3 hours per day of aerosolized StS-WF (40 mg/m3). Dot plots are from 4
mice per group. Data are compared by using the Mann-Whitney test. Bars
represent medians. *P < .05.
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FIG E5. PAFR immunostaining in the human lung. A biopsy specimen of normal tissue was obtained at the
time of biopsy for malignancy. A, Lung tissue from a nonsmoking welder stained with an isotypic control
mAb. There is no specific (brown) staining of epithelial cells. B, Lung tissue from a nonsmoking welder
stained with a PAFR mAb. There is marked specific staining of bronchial epithelial cells and some specific
staining of alveolar epithelial cells. C, Lung tissue from a nonsmoking, non–WF-exposed control subject
stained with an isotypic control mAb. D, Lung tissue from a nonsmoking, non–WF-exposed control subject
stained with a PAFR mAb. There is specific PAFR staining of bronchial epithelial cells (brown).
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FIG E6. Effect of the PAFR blocker CV-3988 (20 mmol/L) on adhesion of S pneumoniae to airway cells after
2 hours of exposure to StS-WF. StS-WF (chromium, 4.1%; iron, 3.9%; manganese, 2.7%; and titanium, 1.5%)
were generated as described in the Methods section by using E308L manual metal arc welding electrodes.
Increased CFU values determined by using quantitative culture reflect increased pneumococcal adhesion
and infection. A, A549 cells plus 275 mg/mL StS-WF. B, BEAS-2B cells plus 200 mg/mL StS-WF. StS-WF stim-
ulates pneumococcal adhesion, and this is attenuated by CV-3988. Data are from 4 separate experiments,
with 3 replicates per experiment. Data are described as means (SEMs) and compared by using 1-way AN-
OVA and the Tukey multiple comparison test. *P < .05, **P < .01, and ***P < .001.
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